Interfering with cellular signaling pathways enhances sensitization to combined sodium butyrate and GCV treatment in EBV-positive tumor cells.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Virus Research

• Publication date

  2008-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.virusres.2008.03.012PMID 18455826
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oncogenic KRAS provides a uniquely powerful and variable oncogenic contribution among RAS family members in the colonic epithelium

  2007cited by this paper
• A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

  2007cited by this paper
• K‐ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment

  2007cited by this paper
• Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents.

  2007cited by this paper
• Cells lytically infected with Epstein-Barr virus are detected and separable by immunoglobulins from EBV-seropositive individuals.

  2006cited by this paper
• DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer.

  2006cited by this paper
• Methylglyoxal downregulates Raf-1 protein through a ubiquitination-mediated mechanism.

  2006cited by this paper
• DNA damage-induced cell death by apoptosis.

  2006cited by this paper
• Ras/MAP kinase pathways are involved in Ras specific apoptosis induced by sodium butyrate.

  2005cited by this paper
• The Interaction of Mitogen-Activated Protein Kinases to Epstein-Barr Virus Activation in Akata Cells

  2004cited by this paper
• Distinct Patterns of Mitogen-Activated Protein Kinase Phosphorylation and Epstein–Barr Virus Gene Expression in Burkitt's Lymphoma Cell Lines versus B Lymphoblastoid Cell Lines

  2004cited by this paper
• Lytic Induction Therapy for Epstein-Barr Virus-Positive B-Cell Lymphomas

  2004cited by this paper
• Epstein–Barr virus: 40 years on

  2004cited by this paper
• Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.

  2004cited by this paper
• Identification of Protein Tyrosine Kinases Required for B-Cell- Receptor-Mediated Activation of an Epstein-Barr Virus Immediate-Early Gene Promoter

  2004cited by this paper
• Virally targeted therapies for EBV-associated malignancies

  2003cited by this paper
• Prospects for anti‐ras drugs

  2002cited by this paper
• The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.

  2002cited by this paper
• Activation of Akt/Protein Kinase B Overcomes a G2/M Cell Cycle Checkpoint Induced by DNA Damage

  2002cited by this paper
• Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors.

  2002cited by this paper
• Protein Kinase C-Independent Activation of the Epstein-Barr Virus Lytic Cycle

  2002cited by this paper
• Changes in the cellular behaviour of human colonic cell line Caco-2 in response to butyrate treatment.

  2002cited by this paper
• Antibodies to Epstein‐Barr virus thymidine kinase: A characteristic marker for the serological detection of nasopharyngeal carcinoma

  2001cited by this paper
• Short-chain fatty acids inhibit invasive human colon cancer by modulating uPA, TIMP-1, TIMP-2, mutant p53, Bcl-2, Bax, p21 and PCNA protein expression in an in vitro cell culture model.

  2001cited by this paper
• Epstein–Barr virus post‐transplant lymphoproliferative disease and virus‐specific therapy: pharmacological re‐activation of viral target genes with arginine butyrate

  2001cited by this paper
• Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells.

  2001cited by this paper
• Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies.

  2001cited by this paper
• Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.

  2000cited by this paper
• Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

  2000cited by this paper
• Epstein-Barr virus--associated diseases in humans.

  2000cited by this paper
• Epstein-Barr Virus Immediate-Early Proteins BZLF1 and BRLF1 Activate the ATF2 Transcription Factor by Increasing the Levels of Phosphorylated p38 and c-Jun N-Terminal Kinases

  2000cited by this paper
• Characterization of the Epstein-Barr virus BALF2 promoter.

  1999cited by this paper
• Divergent Requirements for the MAPKERK Signal Transduction Pathway during Initial Virus Infection of Quiescent Primary B Cells and Disruption of Epstein-Barr Virus Latency by Phorbol Esters

  1999cited by this paper
• Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP)

  1999cited by this paper
• Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers

  1999cited by this paper
• Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption.

  1998cited by this paper
• Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma.

  1998cited by this paper
• MEK Kinase 1, a Substrate for DEVD-Directed Caspases, Is Involved in Genotoxin-Induced Apoptosis

  1998cited by this paper
• MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases?

  1997cited by this paper
• [The mechanisms of Epstein-Barr virus activation in B cells].

  1997cited by this paper
• Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells.

  1996cited by this paper
• Transcription factor ATF2 regulation by the JNK signal transduction pathway

  1995cited by this paper
• Apoptosis in colorectal tumour cells: Induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate

  1995cited by this paper
• Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines.

  1994cited by this paper
• Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.

  1993cited by this paper
• Function and regulation of ras.

  1993cited by this paper
• Use of antigen expressed in bacteria for detection of EBV‐specific thymidine kinase antibodies in sera from patients with nasopharyngeal carcinoma

  1992cited by this paper
• Immunological response of nasopharyngeal carcinoma patients to the Epstein‐Barr‐virus‐coded thymidine kinase expressed in Escherichia coli

  1990cited by this paper
• The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators

  1989cited by this paper
• Characterization of the Epstein-Barr virus-encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems

  1988cited by this paper
• Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus

  1984cited by this paper
• Induction of replication of Epstein-Barr virus DNA by 12-O-tetradecanoyl-phorbol-13-acetate. II. Inhibition by retinoic acid and 9-(2-hydroxyethoxymethyl) guanine.

  1981cited by this paper
• Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.

  1979cited by this paper
• Activation of latent Epstein–Barr virus by antibody to human IgM

  1978cited by this paper

• Epstein-Barr Virus-Encoded miRNAs in Epstein-Barr Virus-Related Malignancy

  2012cites this paper
• A Novel Micro-Linear Vector for In Vitro and In Vivo Gene Delivery and Its Application for EBV Positive Tumors

  2012cites this paper
• Association between Epstein-Barr virus infection and chemoresistance to docetaxel in gastric carcinoma

  2011cites this paper
• Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels.

  2010cites this paper
• Investigational histone deacetylase inhibitors for non-Hodgkin lymphomas

  2010cites this paper
• Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes

  2009cites this paper
• Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

  2009cites this paper
• Cumulative Author Index for 2008

  2008cites this paper